Mason Street Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-13,219
| Closed | -$148K | – | 1531 |
|
|
2017
Q3 | $148K | Buy |
13,219
+462
| +4% | +$5.17K | ﹤0.01% | 1387 |
|
|
2017
Q2 | $140K | Buy |
12,757
+720
| +6% | +$7.9K | ﹤0.01% | 1385 |
|
|
2017
Q1 | $118K | Buy |
12,037
+881
| +8% | +$8.64K | ﹤0.01% | 1407 |
|
|
2016
Q4 | $120K | Buy |
11,156
+875
| +9% | +$9.41K | ﹤0.01% | 1388 |
|
|
2016
Q3 | $105K | Buy |
10,281
+524
| +5% | +$5.35K | ﹤0.01% | 1383 |
|
|
2016
Q2 | $127K | Buy |
+9,757
| New | +$127K | ﹤0.01% | 1314 |
|